These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 2781014)
21. Efficacy and safety of MR imaging with liver-specific contrast agent: U.S. multicenter phase III study. Bluemke DA; Sahani D; Amendola M; Balzer T; Breuer J; Brown JJ; Casalino DD; Davis PL; Francis IR; Krinsky G; Lee FT; Lu D; Paulson EK; Schwartz LH; Siegelman ES; Small WC; Weber TM; Welber A; Shamsi K Radiology; 2005 Oct; 237(1):89-98. PubMed ID: 16126918 [TBL] [Abstract][Full Text] [Related]
22. Gadopentetate dimeglumine as a bowel contrast agent: safety and efficacy. Kaminsky S; Laniado M; Gogoll M; Kornmesser W; Clauss W; Langer M; Claussen C; Felix R Radiology; 1991 Feb; 178(2):503-8. PubMed ID: 1987615 [TBL] [Abstract][Full Text] [Related]
23. Gd-DTPA as a contrast agent in CT. Bloem JL; Wondergem J Radiology; 1989 May; 171(2):578-9. PubMed ID: 2704827 [TBL] [Abstract][Full Text] [Related]
24. Gd-DTPA administered MR imaging of intracranial mass lesions: a comparison with CT and precontrast MR. Mihara F; Hirakata R; Hasuo K; Yasumori K; Yoshida K; Kuroiwa T; Masuda K; Fukui M Radiat Med; 1989; 7(5):227-35. PubMed ID: 2629036 [TBL] [Abstract][Full Text] [Related]
26. [Contrast-enhanced MR imaging using double doses of gadolinium-DTPA in evaluating brain and spinal diseases]. Matsumoto S; Hasuo K; Uchino A; Matsuura Y; Gibo M; Fukui M; Masuda K Nihon Igaku Hoshasen Gakkai Zasshi; 1993 May; 53(5):503-10. PubMed ID: 8327315 [TBL] [Abstract][Full Text] [Related]
27. Recurrent medulloblastoma: frequency of tumor enhancement on Gd-DTPA MR imaging. Rollins N; Mendelsohn D; Mulne A; Barton R; Diehl J; Reyes N; Sklar F AJR Am J Roentgenol; 1990 Jul; 155(1):153-7. PubMed ID: 2112838 [TBL] [Abstract][Full Text] [Related]
28. Gadopentetate dimeglumine-enhanced MR of the brain: clinical utility and safety in patients younger than two years of age. Eldevik OP; Brunberg JA AJNR Am J Neuroradiol; 1994 Jun; 15(6):1001-8. PubMed ID: 8073967 [TBL] [Abstract][Full Text] [Related]
29. [Gd-DTPA in the diagnosis of brain metastasis]. Kornienko VN; Pronin IN Vestn Rentgenol Radiol; 1994; (5):5-10. PubMed ID: 7785209 [TBL] [Abstract][Full Text] [Related]
30. Gadolinium-DTPA-enhanced MR imaging of spinal neoplasms: preliminary investigation and comparison with unenhanced spin-echo and STIR sequences. Stimac GK; Porter BA; Olson DO; Gerlach R; Genton M AJR Am J Roentgenol; 1988 Dec; 151(6):1185-92. PubMed ID: 3055895 [TBL] [Abstract][Full Text] [Related]
31. MR imaging of acute myocardial infarction: value of Gd-DTPA. de Roos A; Doornbos J; van der Wall EE; van Voorthuisen AE AJR Am J Roentgenol; 1988 Mar; 150(3):531-4. PubMed ID: 3257603 [TBL] [Abstract][Full Text] [Related]
38. [Double-dose Gd-DTPA: detectability of intraparenchymal brain metastasis]. Tatsuno S; Hata Y; Tada S Nihon Igaku Hoshasen Gakkai Zasshi; 1996 Oct; 56(12):855-9. PubMed ID: 8940816 [TBL] [Abstract][Full Text] [Related]
39. [Efficacy of gadobenate dimeglumine vs gadopentetate dimeglumine in contrast- enhanced magnetic resonance imaging for diagnosis of solitary brain metastases]. Wang QJ; Wang Y; Xu X; Xiao H; Ma L Nan Fang Yi Ke Da Xue Xue Bao; 2011 Dec; 31(12):1968-73. PubMed ID: 22200693 [TBL] [Abstract][Full Text] [Related]
40. Renal masses: evaluation with gradient-echo Gd-DTPA-enhanced dynamic MR imaging. Eilenberg SS; Lee JK; Brown J; Mirowitz SA; Tartar VM Radiology; 1990 Aug; 176(2):333-8. PubMed ID: 2367649 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]